Log in to save to my catalogue

Ruxolitinib in Aicardi-Goutières syndrome

Ruxolitinib in Aicardi-Goutières syndrome

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2501853005

Ruxolitinib in Aicardi-Goutières syndrome

About this item

Full title

Ruxolitinib in Aicardi-Goutières syndrome

Publisher

New York: Springer US

Journal title

Metabolic brain disease, 2021-06, Vol.36 (5), p.859-863

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Aicardi-Goutières Syndrome (AGS) is a monogenic leukodystrophy with pediatric onset, clinically characterized by a variable degree of neurologic impairment. It belongs to a group of condition called type I interferonopathies that are characterized by abnormal overproduction of interferon alpha, an inflammatory cytokine which action is mediated by t...

Alternative Titles

Full title

Ruxolitinib in Aicardi-Goutières syndrome

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2501853005

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2501853005

Other Identifiers

ISSN

0885-7490,1573-7365

E-ISSN

1573-7365

DOI

10.1007/s11011-021-00716-5

How to access this item